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Abstract
SHIP and SHIP-2 are inositol phosphatases that regulate FccR-mediated phagocytosis through catalytic as well as non-
catalytic mechanisms. In this study we have used two-dimensional fluorescence difference gel electrophoresis (DIGE)
analysis to identify downstream signaling proteins that uniquely associate with SHIP or SHIP-2 upon FccR clustering in
human monocytes. We identified LyGDI as a binding partner of SHIP, associating inducibly with the SHIP/Grb2/Shc complex.
Immunodepletion and competition experiments with recombinant SHIP domains revealed that Grb2 and the proline-rich
domain of SHIP were necessary for SHIP-LyGDI association. Functional studies in primary human monocytes showed that
LyGDI sequesters Rac in the cytosol, preventing it from localizing to the membrane. Consistent with this, suppression of
LyGDI expression resulted in significantly enhanced FccR-mediated phagocytosis.
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Introduction
Fcc receptor (FccR) clustering on monocytes and macrophages
results in the activation of a number of signaling pathways and
culminates in phagocytosis [1]. This process is accompanied by the
release of pro-inflammatory cytokines and reactive oxygen species
that, although required for optimal clearance of immune complex
(IC), will lead to tissue damage if not tightly regulated. FccR
activity and phagocytosis are governed by phosphatases such as
the SH2 (Src Homology 2) domain-containing inositol phospha-
tases SHIP and SHIP-2 [2,3]. These phosphatases share a high
degree of homology within the catalytic domains. However, the
non-catalytic domains that mediate interactions with downstream
signaling proteins are largely divergent [4,5]. Thu SHIP and
SHIP-2 can associate with non-overlapping cytoplasmic signaling
molecules via their non-catalytic domains and these associations
may influence multiple signaling pathways. Little is known about
the molecular details of these associations and their effects on
ensuing biologic responses. Here we have used a highly sensitive
proteomics-based DIGE (two-dimensional fluorescence difference
in gel electrophoresis) approach to identify undiscovered binding
partners of SHIP and SHIP-2, and found that LyGDI associates
with SHIP.
LyGDI (RhoGDIb, RhoGDI2, D4-GDI or GDID4) belongs to
the family of Rho guanidine dissociation inhibitors (RhoGDI) that
regulate the activity of RhoGTPases by stabilizing their cytosolic
GDP-bound inactive form [6,7]. RhoGDI accommodates the C-
terminal isoprenyl motif of RhoGTPases within a hydrophobic
pocket thus sequestering them within the cytosol. Following disso-
ciation from RhoGDI and GDP to GTP exchange, RhoGTPases
are translocated to the plasma membrane via C-terminal isoprenyl
motif, where they activate their downstream effectors such as
PAK and WASP [8]. Putative substrates of LyGDI include the
RhoGTPases RhoA, Cdc42 and Rac, as suggested by in vitro
studies using recombinant LyGDI [9]. Rac plays an important role
in mediating actin cytoskeletal changes during processes such as
phagocytosis and cell locomotion. Consistent with this, overex-
pression of LyGDI results in disruption of the actin cytoskeleton
[10].
Here, we report that SHIP associates with LyGDI downstream
of FccR clustering in human monocytes. This association is indirect
and requires Grb2 as well as the C-terminal proline-rich domain
(PRD) of SHIP. Subsequent experiments showed that LyGDI is
a suppressor of Rac membrane localization in human monocytes
and that it negatively regulates FccR-mediated phagocytosis.
Results
SHIP and SHIP-2 associate with distinct signaling
intermediates upon FccR clustering
To identify non-overlapping binding partners of SHIP and
SHIP-2 we used DIGE analysis. THP-1 cells were stimulated for
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SHIP and SHIP-2 immunoprecipitates were labeled, combined in
equal ratios and separated using two dimensional SDS-PAGE (2D-
PAGE). Based on fluorescence (SHIP-interacting proteins were
red and SHIP-2 interacting proteins were yellow), eight unique
spots were chosen for in-gel trypsin digest (Figure 1A) followed by
LC-MS/MS mass spectrometry analysis. Twenty proteins were
identified as potential binding partners of SHIP or SHIP-2
(Figure 1B) using a MASCOT Daemon database search. Two of
these have been previously reported to associate with SHIP (spot
#5, Grb2) [11] and SHIP-2 (spot #3 actin) [12] thus validating
our methodology. Several proteins identified in this study such as
14-3-3, Ezrin, Radaxin and Moesin (ERM proteins), BiP (GRP78),
HSP90b, protein disulphide isomerase LyGDI and tubulin [13–
19] have been demonstrated to play an important role in actin
dynamics during cytoskeleton remodeling, cellular adhesion and
migration. The observation that SHIP and SHIP-2 associate with
distinct signaling proteins involved in actin dynamics suggests that
the two phosphatases may regulate different aspects of actin
dynamics through non-catalytic mechanisms. Some proteins such
as peroxiredoxin-3 and 14-3-3 can influence ROS production
[20–22].
LyGDI associates with SHIP
Many proteins identified in this study, although important for
regulating actin dynamics and ROS production, have not been
previously reported downstream of FccR activation. We verified
several associations using co-immunoprecipitation (co-IP) assays
(data not shown). For this study we chose to focus on LyGDI,
a regulator of RhoGTPase activity that appeared as a binding
partner of SHIP (spot #6). Because RhoGTPases play an im-
portant role in the actin cytoskeletal rearrangements associated
with FccR-mediated phagocytosis [23,24], we explored the
possibility that LyGDI regulates this process. First, to ascertain
whether the SHIP-LyGDI association was physiologically rele-
vant we performed co-IP assays. SHIP immunoprecipitates from
FccRIIa/IIb-stimulated THP-1 cells were analyzed by Western
blotting for LyGDI. A time-dependent increase in the association
between SHIP and LyGDI was observed (Figure 2A, upper panel).
SHIP was also tyrosine phosphorylated under these condition as
previously reported (Figure 2A, middle panel) [25], indicative of
SHIP membrane translocation and activity. Equivalent loading of
protein in all lanes was confirmed by reprobing the membranes
with SHIP antibody (Figure 2A, lower panel).
Next, we assessed whether SHIP-LyGDI complex formation
occurred downstream of other FccR known to recruit and activate
SHIP. We clustered FccRI and FccRIIa using receptor-specific
F(ab’)2 antibodies and measured SHIP-LyGDI association as
described above. Results showed that SHIP inducibly associated
with LyGDI downstream of both FccRI and FccRIIa, with similar
kinetics (Figure 2B & C).
FccR clustering induces a SHIP-LyGDI multimolecular
complex involving Shc and Grb2
We then examined downstream molecules of FccR that may be
responsible for this SHIP-LyGDI complex formation. The first
candidate was Shc, as T-cell receptor activation is known to
induce LyGDI-Shc association in Jurkat cells [26]. In accordance
with this we found that FccR clustering in THP-1 cells led to
LyGDI-Shc association (Figure 3A). FccR clustering has been
shown to induce association between SHIP and Shc (Figure 3B),
while Grb2 is constitutively associated with SHIP (Figure 3C)
[27,28]. Consistent with this, we found that Grb2 co-precipitated
with LyGDI upon FccR clustering (Figure 3D).
Grb2 is necessary for FccR-mediated SHIP-LyGDI
association
To further decipher the role of Shc and Grb2 in mediating the
SHIP-LyGDI association, we performed immunodepletion stud-
ies. Shc (Figure 4A, upper panel) and Grb2 (Figure 4A, middle
panel) were immunodepleted from resting and FccRIIa/IIb-
stimulated THP-1 lysates. We then immunoprecipitated SHIP
from the immunodepleted lysates and probed for LyGDI by Wes-
tern blotting. Results showed that FccR-induced SHIP-LyGDI
association occurred in non-depleted lysates (lane 2). Surprisingly,
we also saw this association in Shc-depleted lysates upon FccR
activation. However, in Grb2-depleted lysates (Figure 4B, upper
panel, lane 6) SHIP-LyGDI association was dramatically reduced.
Figure 1. SHIP and SHIP-2 associate with unique binding partners. (A) DIGE was performed as described in Materials and Methods. Spots in
green are control immunoprecipitations (IP), the spots in yellow are binding partners of SHIP, while spots in red are binding partners of SHIP-2. Black
circles indicate the 8 spots that were cut out and subjected to in-gel trypsin digest followed by LC-MS/MS and protein identification using a database
search. The black arrow shows the spot corresponding to LyGDI. (B) This table summarizes the binding partners of SHIP or SHIP-2 that were identified.
doi:10.1371/journal.pone.0021175.g001
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(CD32) antibody followed by goat F(ab’)2 anti-mouse IgG. SHIP was immunoprecipitated from resting ‘R’ and activated ‘A’ cells and analyzed by
Western blotting (IB) with anti-LyGDI (upper panel). Control IPs were performed using normal mouse IgG. The same membrane was reprobed with
anti-phosphotyrosine (pY) (middle panel) and anti-SHIP (lower panel). Similar co-immunoprecipitation assays were performed from cells stimulated
using (B) F(ab’)2 fragments of FccRI antibody 32.2 and goat F(ab’)2 anti-mouse IgG secondary antibody, and (C) F(ab’)2 fragments of FccRIIa antibody
IV.3 and goat F(ab’)2 anti-mouse IgG secondary antibody.
doi:10.1371/journal.pone.0021175.g002
Figure 3. Shc and Grb2 are present in SHIP-LyGDI complexes upon FccR clustering. THP-1 cells were stimulated for different time points
using anti-CD32 followed by goat anti-mouse F(ab’)2 IgG secondary antibody. (A) LyGDI was immunoprecipitated from resting and activated cells and
analyzed by Western blotting with anti-Shc (upper panel). The same membrane was reprobed with anti-LyGDI to ensure equivalent protein loading
(lower panel). Control IPs were done using normal goat IgG. (B) SHIP was immunoprecipitated from resting and activated cells and analyzed by
Western blotting with anti-Shc (upper panel). The same membrane was reprobed with anti-SHIP to ensure equivalent protein loading (lower panel).
Control IPs were done using normal mouse IgG. (C) SHIP was immunoprecipitated from resting and activated cells and analyzed by Western blotting
with anti-Grb2 (upper panel). The same membrane was reprobed with anti-SHIP to ensure equivalent protein loading (lower panel). Control IPs were
done using normal mouse IgG. (D) LyGDI was immunoprecipitated from resting and activated cells and analyzed by Western blotting with anti-Grb2
(upper panel). The same membrane was reprobed with anti-LyGDI to ensure equivalent protein loading (lower panel). Control IPs were done using
normal goat IgG. All co-IP results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0021175.g003
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the SHIP-LyGDI complex, only Grb2 is required for LyGDI
association.
Grb2 contains a central SH2 domain that is flanked by an SH3
(Src Homology 3) domain on either side. SHIP interaction with
Grb2 is mediated via the PRD of SHIP. Because Grb2 is nece-
ssary for SHIP-LyGDI association, we hypothesized that FccR
clustering led to an indirect association between SHIP and LyGDI
via Grb2, which depended on the C-terminal PRD of SHIP.
To test this hypothesis we generated GST-SH2 and GST-PRD
fusion constructs of SHIP using standard subcloning techniques
followed by overexpression and purification from E.coli BL21(DE3)
(Figure 4C). Next, we determined whether SHIP GST-SH2 and
SHIP GST-PRD fusion proteins were functional. In our peptide
Figure 4. Grb2 is necessary for FccR-induced SHIP-LyGDI association. THP-1 cells were stimulated for 15 minutes using CD32 antibody
followed by goat anti-mouse IgG secondary antibody. Lysates were made and immunodepleted for Shc or Grb2. (A) Non-depleted, Shc-depleted and
Grb2-depleted lysates from resting and activated cells were analyzed by Western blotting with anti-Shc (upper panel) and anti-Grb2 (middle panel).
The same membrane was reprobed with anti-GAPDH (lower panel) to ensure equivalent protein loading. (B) SHIP was immunoprecipitated from
resting and activated immunodepleted lysates and analyzed by Western blotting with LyGDI antibody (upper panel). The same membrane was
reprobed with anti-SHIP to ensure equivalent protein loading (lower panel). Control IPs were done using normal mouse IgG. (C) 0.5 mg of purified
GST, SHIP-GST-SH2 and SHIP-GST-PRD fusion proteins were analyzed by Western blotting with anti-GST antibody. (D) N-terminal biotinylated control
peptide ‘C’ or phosphorylated peptide containing to the FccRIIb ITIM sequence (PITIM) immobilized on NeutrAvidin beads were used to pulldown
SHIP-GST-SH2, SHIP-GST-PRD or GST alone from solution. Bead-bound proteins were analyzed by Western blotting with GST antibody. (E) GST, SHIP-
GST-SH2 or SHIP-GST-PRD were added to resting ‘R’ or FccRIIa/IIb-stimulated ‘A’ THP-1 lysates and GST pulldowns were performed by adding
glutathione agarose beads. Bead-bound proteins were analyzed by Western blotting with anti-Grb2 (upper panel). The same membrane was
reprobed with anti-GST (lower panel). (F) GST, SHIP-GST-SH2 or SHIP-GST-PRD were added to resting ‘R’ or FccRIIa/IIb-stimulated ‘A’ THP-1 lysates and
LyGDI was immunoprecipiated. The immunoprecipitates were analyzed by Western blotting for SHIP (upper panel). The same membrane was
reprobed with anti-LyGDI antibody (lower panel).
doi:10.1371/journal.pone.0021175.g004
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containing phosphorylated ITIM of FccRIIb (PITIM), we found
that the SHIP GST-SH2 domain specifically associated with PITIM
but not SHIP GST-PRD or GST alone (Figure 4D). This was as
previously reported [29]. Next, we observed that Grb2 associated
with SHIP GST-PRD in both resting and FccRIIa/IIb-stimulated
THP-1 lysates. However, it did not associate with SHIP GST-SH2
(Figure 4E, upper panel), in accordance with previous studies [30].
Anti-GST antibody reprobes of the same membrane confirmed
that equivalent amounts of GST proteins were used (Figure 4E,
lower panel).
Next, to access whether SHIP-LyGDI association required the
C-terminal PRD of SHIP, we performed competition assays where
an excess of SHIP GST-SH2 or SHIP GST-PRD was added to
resting and FccRIIa/IIb-stimulated THP-1 lysates. LyGDI
immunoprecipitates from these lysates were probed for SHIP by
Western blotting. SHIP-LyGDI association could be detected
in the presence of SHIP GST-SH2 or GST alone but was dra-
matically reduced in the presence of SHIP GST-PRD (Figure 4F,
upper panel). Membranes were reprobed with anti-LyGDI as
a loading control (Figure 4F, lower panel). Data from three
independent experiments were analyzed by Student’s t-test. No
significant difference in SHIP-LyGDI association was observed
in presence of SHIP GST-SH2 or GST alone. However, SHIP
GST-PRD was able to disrupt SHIP-LyGDI interaction (p-value,
0.053). These results suggest that the C-terminal PRD of SHIP is
required for mediating the SHIP-LyGDI association.
LyGDI influences Rac localization downstream of FccR
activation
LyGDI is a guanidine dissociation inhibitor for RhoGTPases
such as Rac. Previous in vitro studies using recombinant LyGDI
demonstrated that LyGDI can negatively regulate the bioche-
mical activity of RhoGTPases [9]. Hence, we next examined the
influence of LyGDI on Rac localization in human monocytes. We
knocked down LyGDI in PBM using nucleofection (Figure 5A)
and verified cell viability using trypan blue staining. To rule out
the possibility that knockdown affected expression of FccR, we
stained for FccR and analyzed receptor levels using flow cytometry
(Figure 5B).
We fluorescently labeled Rac and examined its localization in
control and knockdown cells. We found distinct punctate areas in
Figure 5. LyGDI influences Rac membrane localizaation. (A) 1610
7 PBM were transfected with either scrambled or LyGDI siRNA. Western
blotting was done to measure LyGDI after 48 hours (upper panel). The membrane was reprobed with anti-actin to ensure equivalent loading (lower
panel). Numbers in the upper panel are mean optical density (arbitrary units) normalized to actin. (B) Control and LyGDI siRNA-transfected samples
were tested for FccR expression by flow cytometery analysis. Overlay histograms show FccR staining in secondary-only antibody controls (gray),
control siRNA-transfected (black) and si-LyGDI-transfected (red). (C) Control and LyGDI siRNA-transfected PBMs were stained with mouse anti-Rac
followed by Alexa flour 555 conjugated to goat anti-mouse IgG, F(ab’)2 fragment. (D) The fold change in Rac membrane localization in control versus
LyGDI siRNA-transfected PBMs was quantified as described in Materials and Methods.
doi:10.1371/journal.pone.0021175.g005
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LyGDI knockdown there was a reduction in these areas with a
concurrent increase in membrane localization (Figure 5C & 5D).
Because membrane association of Rac follows Rac activation and
is required for downstream activation of Rac effectors [8,31,32],
these results suggest that LyGDI negatively regulates Rac
activation by sequestering Rac within the cytosol.
LyGDI negatively regulates FccR-mediated phagocytosis
Rac activation is necessary for promoting actin assembly and
subsequent phagocytosis downstream of FccR activation [23,24].
Hence, we predicted that LyGDI would have an effect on FccR-
mediated phagocytosis. We transfected THP-1 with either control
or LyGDI siRNA and measured phagocytosis of antibody-coated
sheep red blood cells (SRBC). We found a significant increase in
the phagocytic index of cells knocked down for LyGDI (Figure 6A).
Next, we confirmed these findings in primary human mono-
cytes. PBM from 6 donors were subjected to the same siRNA and
phagocytosis assays. As shown in Figure 6B, knockdown of LyGDI
led to a significant increase in the phagocytic index. These results
strongly suggest that LyGDI is a negative regulator of FccR-
mediated phagocytosis.
Discussion
SHIP and SHIP-2 are important regulatory phosphatases that
play distinct roles despite similar catalytic activity, as suggested
by in vivo studies [33,34]. They are very similar in domain
Figure 6. LyGDI is a negative regulator of FccR-mediated phagocytosis. Control and LyGDI siRNA-transfected THP-1 (A) or PBM (B) were
incubated with fluoresceinated, IgG-coated sheep red blood cells (SRBC) at 37uC for 40 minutes. Phagocytosis was measured by counting the total
number of SRBC ingested by 100 transfectants and is plotted as the phagocytic index. Three independent experiments were performed and scored in
a blinded fashion. Data were analyzed by Student’s t-test (* denotes p,0.05).
doi:10.1371/journal.pone.0021175.g006
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[27,35,36]. Each contains an N-terminal SH2 domain, the central
catalytic domain that catalyzes hydrolysis of PtdIns(3,4,5)P3, a key
secondary messenger in the PI3K pathway, and a C-terminal PRD
harboring NPXY motifs. Despite their high degree of sequence
homology within the catalytic regions and similar enzymatic
activity, SHIP and SHIP-2 have largely divergent non-catalytic
domains that result in differential association with signaling
proteins. This suggests that they may serve both overlapping and
non-overlapping functions. For example, previous studies have
demonstrated that SHIP associates with Grb2, a protein involved
in growth factor signaling, whereas SHIP-2 associates with Abl
[11]. Likewise, it was demonstrated that only SHIP-2 associates
with actin-binding proteins such as filamin and p130Cas that are
involved in cytoskeletal rearrangement [37,38]. Associations
mediated by the non-catalytic domains are known to influence
key signaling pathways in B cells and macrophages. In macro-
phages, SHIP downregulation of FccR-mediated IL-1b produc-
tion is independent of catalytic activity but requires functional
non-catalytic domains [39]. In B cells SHIP exerts a negative
influence on the Ras signaling pathway by binding to phosphor-
ylated Shc via its non-catalytic domain, thereby sequestering
binding sites for the Grb2/Sos complex [28,40]. Additionally,
SHIP’s association with p62Dok via its non-catalytic domain
results in hyper-phosphorylation of p62Dok, turning off Ras sig-
naling through the activation of RasGAP [41]. Therefore, protein
interactions mediated by the non-catalytic domains of SHIP(s)
have important biological consequences.
To identify as-yet undiscovered proteins that uniquely associate
with SHIP or SHIP-2 we have made use of DIGE analysis. DIGE
is traditionally used to quantify relative abundances and monitor
differences in expression profiles of proteins in a given sample [42].
Here, we have combined the selectivity of co-IPs with the
sensitivity of DIGE to directly compare the association profiles of
two closely related protein SHIP and SHIP-2. The system is not
quantitative because of the nature of co-IP but we were able to
identify several proteins that uniquely associated with either SHIP
or SHIP-2 upon FccR activation. Not surprisingly, many have
been reported to play an important role in mediating actin
dynamics. For example, ERM proteins have been shown to be
important for polymerization and organization of actin filaments
[13–15]. They also inhibit stress fibers by blocking RhoA. BiP
(GRP78) promotes cell spreading and cell polarity by influencing
Focal Adhesion Kinase (FAK) activity [16]. Protein disulphide
isomerases are important for cell migration and invasion [17].
14-3-3 is an adaptor molecule that can influence actin dynamics
by associating with other proteins. Association of 14-3-3 with
IRSp53 can modulate filopodial dynamics while it influences actin
stress fiber formation through association with ankyrin repeat
containing protein [18]. 14-3-3 can also disrupt cell migration
upon association with MK5 [19].
Both SHIP and SHIP-2 are recruited to phagocytic cups upon
FccR clustering and are known to influence actin dynamics in-
directly through SHIP’s catalytic activity [2,43–45]. This collec-
tively suggests that SHIP proteins may utilize both catalytic as well
as non-catalytic mechanisms for controlling actin dynamics during
cellular activation. The observation that SHIP and SHIP-2
associate with distinct signaling intermediates suggests that the
two proteins may regulate different aspects of actin dynamics.
Understanding such differences will not only enhance our under-
standing of FccR-mediated signaling responses but also allow us
to design more specific therapeutic modulators to selectively
alter SHIP functions without altering the overall catalytic func-
tion within the context of a pathological condition.
Some of the other proteins that were identified as binding part-
ners of SHIP(s) such as progranulin [20], peroxoredoxin-3 [21] and
14-3-3 [22] have a role in regulation of reactive oxygen species
(ROS) generation. ROS production accompanies FccR-mediated
phagocytosis and is tightly regulated by SHIP catalytic activity.
Therefore, association of SHIP(s) with different signaling molecules
can alter various functions downstream of FccR activation. However,
the effects of these differential associations remain to be tested.
Our results suggest that the FccR-mediated association of
LyGDI with SHIP required Grb2. The hydrolysis of PtdIns-
(3,4,5)P3 by SHIP is known to downregulate the activity of
proteins such as Vav, thereby decreasing Rac activation and
subsequent phagocytosis [46]. We speculate that association bet-
ween SHIP and LyGDI points to a novel, non-catalytic means by
which SHIP may additionally downregulate FccR activity by
stabilizing LyGDI-Rac association. Further studies need to be
done to test this hypothesis.
FccR function has been implicated in both the pathophysio-
logy of autoimmune diseases and in mediating cytotoxic effects of
monoclonal anti-tumor antibodies [47–49]. However, targeting its
downstream regulator SHIP has proven difficult. Results from
this study have uncovered another molecule that plays a role in
SHIP-mediated regulation and that might be a putative target for
therapy.
Materials and Methods
Cell antibodies and reagents
THP-1 cells were obtained from the ATCC and maintained in
RPMI supplemented with 5% fetal bovine serum. Anti-Rac anti-
body was purchased from Chemicon International (Temecula,
CA). Phospho-tyrosine (pY) and SHIP antibodies were from Cell
Signaling Technology (Beverly, MA). Human CD32 (FccRIIa/
IIb) antibody was purchased from BD Pharmingen (San Diego,
CA). The F(ab’)2 of human FccRI (32.2), human FccRIIa (IV.3)
and human FccRIIIa (3 g8) antibody were obtained from
Medarex (Princeton, NJ). Goat anti-mouse F(ab’)2 antibody was
from Jackson ImmunoResearch (West Grove, PA). LyGDI, actin
and HRP-conjugated secondary antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA). siRNA constructs for LyGDI
were also from Santa Cruz.
Immunoprecipitation, Immunodepletion and Western
blotting
THP-1 cells were activated using monoclonal F(ab’)2 antibodies
against FccRI (32.2), FccRIIa (IV.3) or FccRIIa/IIb (CD32)
followed by goat F(ab’)2 anti-mouse IgG secondary antibody.
Resting and activated cells were lysed in TN1 lysis buffer and post-
nuclear lysates were incubated overnight with the specified
antibodie followed by 60-minute incubation at 4uC with protein
G-agarose beads (Gibco BRL, Grand Island, NY). Immunopre-
cipitations with appropriate control antibodies were performed in
lysates from resting cells. After incubation, beads were washed in
TN1 lysis buffer, boiled in SDS sample buffer for 5 minutes and
subjected to SDS/PAGE. Proteins were transferred to nitrocellu-
lose filter probed with the specified antibodies and developed by
enhanced chemiluminescence. For immunodepletion studie the
protein of interest was immunodepleted from resting and activated
THP-1 lysates by incubating overnight with the specified
antibodies and protein-G-agarose beads.
Generation of GST-SHIP SH2 and PRD DNA contructs
DNA sequences for the SHIP SH2 and PRD domains were
isolated by polymerase chain reaction (PCR) from pcDNA3.
LyGDI Regulates FccR-Mediated Phagocytosis
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Amplification and addition of EcoR1 and Xho1 restriction sites
was done using the following primers: N-SH2, 59-GGAATT-
CATGGCCTCAGTGTGTGGGACAC-39 and 59-ACCGGCT-
CGAGGTCTGGCTCTCTCTCCCCCTC-39; C-PRD, 59-GG-
AATTCTCCAGTGGAATGAAATGCTTGAAG-39 and 59-AC-
CGGCTCGAGTCACTGCATGGCAGTCCTGCC-39. PCR
products were digested with EcoRI and Xho1, then ligated into
pGEX-4T-1(Amersham bioscience Piscataway, NJ) to generate
GST fusion constructs. All final constructs were analyzed by
dideoxy sequencing.
Purification of GST-SH2 and GST-PRD SHIP recombinant
proteins
E. coli BL21(DE3) cells were transformed with either pGEX-4T-
1-SH2 SHIP or pGEX-4T-1-PRD SHIP plasmids and grown in
LB medium to the mid-log phase, then induced by 300 mM
isopropyl b-D-thiogalactoside (IPTG) for 3 h at 30uC. Cells were
harvested by centrifugation, resuspended in lysis buffer (10 mM
Na2HPO4, pH 7.2, 1 mM EDTA, 1 mg/mL aprotonin and
leupeptin, 1 mg/mL of p122 protease cocktail inhibitor, 1 mg/mL
lysozyme and 5 mg/mL of protamine sulphate) followed by soni-
cation on ice. GST fusion proteins were purified from crude lysates
on pre-equlibriated GST agarose columns as previously described
[50]. Eluted proteins were dialyzed overnight in dialysis buffer
(50 mM Tri pH 8.0, 100 mM NaCl and 1 mM EDTA) and
concentrated in an Amicon concentrator to approximately
3.5 mg/mL. After concentration and addition of glycerol (final
33%), protein was snap-frozen in liquid nitrogen and stored at
280uC.
GST pulldown Assays
Lysates from resting and FccRIIa/IIb-stimulated THP-1 cells
were incubated with 5 mg of GST, SHIP-GST-SH2 or SHIP-
GST-PRD plus a 50 ml slurry of glutathione-agarose beads (Sigma,
Saint Loui MO). Samples were rocked overnight at 4uC. Beads
were washed twice with TN1 lysis buffer and analyzed by Western
blotting using the specified antibodies.
Peptide pulldown Assays
N-terminal biotinylated control peptide, C- (ETADG-
GYMTLNPRAPTDDDKNIYLTLG) and N-terminal biotiny-
lated peptide containing the phophorylated ITIM sequence of
FccRIIb, PITIM (EAENTITpYSLLKH) with 95% purity were
from Invitrogen (Carlsbad, CA). 1.0 mg of GST, SHIP-GST-SH2
or SHIP-GST-PRD was added to 1 mL of TN1 lysis buffer
containing 5 mg of N-terminal biotinylated control peptide (non-
phosphorylated) or the phospho-peptide and rocked at 4uC for
2 hours. Subsequently, the peptides were pulled down by addition
of 25 mL of NeutrAvidin beads (Thermo Fisher Scientific Inc.,
Rockford, IL) and incubated on a rocker at 4uC for an additional
hour. Beads were collected, washed twice in TN1 lysis buffer and
analyzed by Western blotting using the specified antibodies.
Competition assays
THP-1 cells were either left unstimulated or stimulated for 15
minutes with FccRIIa/IIb (CD32) plus goat anti-mouse F(ab’)2
antibody. Protein lysates were made and incubated on a rocker for
2 hours at 4uC with 5 mg of GST, SHIP-GST-SH2 or SHIP-GST-
PRD or GST plus 2 mg of anti-LyGDI. 30 mL of protein G-
agarose beads were then added and the lysates incubated for an
additional hour. Beads were then collected, washed twice with
TN1 lysis buffer and boiled in SDS sample buffer for analysis by
Western blotting. Western blots were quantitated using ImageJ
software (NIH).
Isolation of PBM
CD14-positive PBM were isolated from buffy coats using the
MACS monocyte isolation kit (Miltenyi Biotech, Auburn, CA) as
described previously [51]. The purity of monocytes was .97% as
assessed by flow cytometry using anti-CD14 staining.
Transfections
THP-1 or PBM were transfected with siRNA constructs using
the Amaxa Nucleofector apparatus (Amaxa biosystem Colonge,
Germany). Briefly, 1610
7 cells were resuspended in 100 mL of Cell
Line Nucleofector Solution T (Amaxa Biosystems) and nucleo-
fected with either scrambled or LyGDI siRNA. Immediately after
transfection the cells were transferred to 10 mL of pre-warmed
media (RPMI supplemented with 10% FBS) and subsequently
cultured in 12-well plates for 48 hours at 37uC. For PBM the
media was supplemented with M-CSF (20 ng/mL).
Flow cytometry analysis for FccR expression
Control and LyGDI siRNA-transfected samples were tested for
FccR expression by incubating with F(ab’)2 antibodies against
FccRI (32.2), FccRIIa (IV.3) or FccRIIIa (3 g8) at the concen-
tration of 1 mg/mL for 30 minutes at 4uC. Cells were washed twice
with PBS and then incubated with FITC-conjugated goat F(ab’)2
anti-mouse IgG secondary antibody for 30 minutes at 4uC. After
washing again with PBS they were fixed in 1% Paraformaldehyde
(PFA) and analyzed by flow cytometry on a FACS Calibur flow
cytometer (BD Bioscience San Jose, CA), recording 10,000 events
per condition.
Fluorescence Microscopy
Control and LyGDI siRNA-transfected PBMs were fixed in 4%
PFA and permeabilized with 0.2% triton X-100. After blocking
with goat serum the cells were stained with mouse anti-Rac
antibody followed by Alexa flour 555 conjugated to goat anti-
mouse IgG, F(ab’)2 fragment to detect Rac. Samples were read
using a Zeiss Meta 510 multiphoton confocal microscope (Carl
Zeis Jena, Germany) for enhanced resolution. Quantification of
Rac protein was achieved using Adobe Photoshop CS5 Histogram
analysis as previously described [52]. Briefly, the maximal (Rac:
Alexa flour 555-red) level was set on each image to standardize
protein expression per image using the information setting for
RGB. After, a macro was set-up to determine unbiased protein
expression in either the cytosol or at the cell periphery. The
designated red pixels are converted to black using: Color Select -
Color Range - Inverse - Delete - Threshold - Histogram, and the
percent of black pixels per field is recorded. Using the batch
feature, all images are quantified in the same manner by the
software.
Phagocytosis Assays
Phagocytosis assays were performed as previously described
[51]. Briefly, IgG-coated PKH26-labeled sheep red blood cells
(SRBC) were added to siRNA-transfected THP-1 or PBM. Cells
were pelleted by low-speed centrifugation followed by incuba-
tion for 40 minutes at 37uC. Cells were then subjected to brief
hypotonic lysis with water prior to fixation in PFA and analyzed
by fluorescence microscopy in a blinded fashion. Phagocytic
index was defined as the total number of RBCs ingested by 100
phagocytes.
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A) Cydye labeling. SHIP and SHIP-2 were immunopre-
cipitated (IP) from FccRIIa/IIb stimulated THP-1 cells for 15
minutes as described above. Proteins were extracted from the
immunoprecipitates using extraction buffer (8 M urea and 4%
CHAPS), precipitated with trichloroacetic acid and resuspended in
Tris buffer (30 mM Tris pH 8.5, 8 M urea and 4% CHAPS) for
cyanine dye labeling. Under similar condition control IP for SHIP
and SHIP-2 were performed using normal mouse and normal goat
IgG respectively. Monofunctional CyDyes NHS esters (GE
Healthcare, Pataskala, OH) were used with three different fluo-
rescent colors (Cy3, Cy5 and Cy2) for SHIP IP, SHIP-2 IP
and control IP respectively, incubated for 30 minutes at room
temperature and the reaction was quenched by addition of 1 mLo f
10 mM lysine. B) Isoelectric focusing (IEF): The CyDye-
labeled samples were mixed in a 1:1:1 ratio, and used to rehydrate
immobilon pH 3–10 strips overnight under mineral oil. The strips
were focused on an IPGphorII IEF under mineral oil in a ceramic
manifold. After focusing, the strips were equilibrated in
equilibration buffer A (50 mM Tris-Cl pH 8.8, 6 M Urea, 30%
glycerol, 1.0% saturated bromophenol blue solution, 2% SD
65 mM DTT) for 15 minute followed by equilibration buffer B
(50 mM Tris-Cl pH 8.8, 6 M Urea, 30% glycerol, 1.0% saturated
bromophenol blue solution, 2% SD 135 mM iodoacetamide) for
15 minutes and rinsed in 1x SDS-loading buffer. The strips were
then placed in an 8% SDS-PAGE minigel sealed in place with
sealing solution (0.5% agarose, 1.0% saturated bromophenol blue
solution, 98.5% SDS-PAGE running buffer) and then subjected to
SDS-PAGE. Gels were rinsed with water and immediately
scanned for the three CyDye wavelengths. Eight spots were cut
out and subjected to in-gel digest with trypsin followed by LC-
MS/MS (Thermo Finnigan LTQ, Thermo Scientific Inc., Odessa,
TX) and protein identification using database search (MASCOT
Daemon, Matrix science, Boston, MA).
Statistical Analysis. Data were analyzed using Student’s
t-testtotestforstatisticallysignificantdifferences,whereappropriate.
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